| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Bromodomain inhibitor OTX015 in patients with acute leukaemia: a dose-escalation, phase 1 study
|
Berthon, Céline
|
|
2016
|
3 |
4 |
p. e186-e195
nvt p.
|
article
|
| 2 |
Bromodomain inhibitor OTX015 in patients with lymphoma or multiple myeloma: a dose-escalation, open-label, pharmacokinetic, phase 1 study
|
Amorim, Sandy
|
|
2016
|
3 |
4 |
p. e196-e204
nvt p.
|
article
|
| 3 |
Caesarean delivery and risk of childhood leukaemia: a pooled analysis from the Childhood Leukemia International Consortium (CLIC)
|
Marcotte, Erin L
|
|
2016
|
3 |
4 |
p. e176-e185
nvt p.
|
article
|
| 4 |
Correction to Lancet Haematol 2016; 3: e176, e180
|
|
|
2016
|
3 |
4 |
p. e162-
1 p.
|
article
|
| 5 |
Dissecting idiopathic multicentric Castleman's disease
|
Dupin, Nicolas
|
|
2016
|
3 |
4 |
p. e153-e154
nvt p.
|
article
|
| 6 |
Hope for BET inhibition in patients with leukaemia or lymphoma
|
Kharfan-Dabaja, Mohamed A
|
|
2016
|
3 |
4 |
p. e157-e158
nvt p.
|
article
|
| 7 |
Idiopathic multicentric Castleman's disease: a systematic literature review
|
Liu, Amy Y
|
|
2016
|
3 |
4 |
p. e163-e175
nvt p.
|
article
|
| 8 |
Real life studies and good clinical practice
|
Stephan, Dominique
|
|
2016
|
3 |
4 |
p. e160-
1 p.
|
article
|
| 9 |
Real life studies and good clinical practice – Authors' reply
|
Ageno, Walter
|
|
2016
|
3 |
4 |
p. e160-e161
nvt p.
|
article
|
| 10 |
Stressful exit from the womb and risk of childhood leukaemia
|
Wiemels, Joseph
|
|
2016
|
3 |
4 |
p. e155-e156
nvt p.
|
article
|
| 11 |
Technological advances or Emperor's new clothes?
|
The Lancet Haematology,
|
|
2016
|
3 |
4 |
p. e149-
1 p.
|
article
|
| 12 |
The collaborative network approach: a new framework to accelerate Castleman's disease and other rare disease research
|
Fajgenbaum, David C
|
|
2016
|
3 |
4 |
p. e150-e152
nvt p.
|
article
|
| 13 |
The 2015 Focus on Haematology winner
|
The Lancet Haematology,
|
|
2016
|
3 |
4 |
p. e159-
1 p.
|
article
|
Journal description